Lutein and brain function

Foods

Volumn 4, Issue 4, 2015, Pages 547-564

  Erdman, John W ^a   Smith, Joshua W ^a   Kuchan, Matthew J ^b   Mohn, Emily S ^c   Johnson, Elizabeth J ^c   Rubakhin, Stanislav S ^a   Wang, Lin ^a   Sweedler, Jonathan V ^a   Neuringer, Martha ^d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b ABBOTT LABORATORIES   (United States)

^c TUFTS UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Animal models; Brain function; Carotenoids; Lutein; Monkeys

Indexed keywords

EID: 84964715208     PISSN: None     EISSN: 23048158     Source Type: Journal    
DOI: 10.3390/foods4040547     Document Type: Article

References (80)

1. Johnson, E.J.; Vishwanathan, R.; Johnson, M.A.; Hausman, D.B.; Davey, A.; Scott, T.M.; Green, R.C.; Miller, L.S.; Gearing, M.; Woodard, J.; et al. Relationship between serum and brain carotenoids, α-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the georgia centenarian study. J. Aging Res. 2013, 2013, 951786, doi:10.1155/2013/951786.
2. Vishwanathan, R.; Iannaccone, A.; Scott, T.M.; Kritchevsky, S.B.; Jennings, B.J.; Carboni, G.; Forma, G.; Satterfield, S.; Harris, T.; Johnson, K.C.; et al. Macular pigment optical density is related to cognitive function in older people. Age Ageing 2014, 43, 271–275.
3. Feeney, J.; Finucane, C.; Savva, G.M.; Cronin, H.; Beatty, S.; Nolan, J.M.; Kenny, R.A. Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol. Aging 2013, 34, 2449–2456.
4. Renzi, L.M.; Dengler, M.J.; Puente, A.; Miller, L.S.; Hammond, B.R. Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiol. Aging 2014, 35, 1695–1699.
5. Vishwanathan, R.; Neuringer, M.; Snodderly, D.M.; Schalch, W.; Johnson, E.J. Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr. Neurosci. 2013, 16, 21–29.
6. Johnson, E.J.; Neuringer, M.; Russell, R.M.; Schalch, W.; Snodderly, D.M. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Investig. Ophthalmol. Vis. Sci. 2005, 46, 692–702.
7. Rubakhin, S.S.; Romanova, E.V.; Nemes, P.; Sweedler, J.V. Profiling metabolites and peptides in single cells. Nat. Methods 2011, 8, S20–S29.
8. Romanova, E.V.; Aerts, J.T.; Croushore, C.A.; Sweedler, J.V. Small-volume analysis of cell-cell signaling molecules in the brain. Neuropsychopharmacology 2014, 39, 50–64.
9. Craft, N.E.; Haitema, T.B.; Garnett, K.M.; Fitch, K.A.; Dorey, C.K. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J. Nutr. Health Aging 2004, 8, 156–162.
10. Li, B.; Vachali, P.; Frederick, J.M.; Bernstein, P.S. Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry 2011, 50, 2541–2549.
11. Bhosale, P.; Larson, A.J.; Frederick, J.M.; Southwick, K.; Thulin, C.D.; Bernstein, P.S. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J. Biol. Chem. 2004, 279, 49447–49454.
12. Johnson, E.J. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr. Rev. 2014, 72, 605–612.
13. Li, B.; Vachali, P.P.; Gorusupudi, A.; Shen, Z.; Sharifzadeh, H.; Besch, B.M.; Nelson, K.; Horvath, M.M.; Frederick, J.M.; Baehr, W.; et al. Inactivity of human β,β-carotene-9′,10′-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment. Proc. Natl. Acad. Sci. 2014, 111, 10173–10178.
14. Snodderly, D.M. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 1995, 62, 1448–1461.
15. SanGiovanni, J.P.; Neuringer, M. The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: Promise of molecular genetics for guiding mechanistic and translational research in the field. Am. J. Clin. Nutr. 2012, 96, 1223S–1233S.
16. Malinow, M.R.; Feeney-Burns, L.; Peterson, L.H.; Klein, M.L.; Neuringer, M. Diet-related macular anomalies in monkeys. Investig. Ophthalmol. Vis. Sci. 1980, 19, 857–863.
17. Leung, I.Y.-F.; Sandstrom, M.M.; Zucker, C.L.; Neuringer, M.; Snodderly, D.M. Nutritional manipulation of primate retinas, II: Effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 2004, 45, 3244–3256.
18. Barker, F.M.; Snodderly, D.M.; Johnson, E.J.; Schalch, W.; Koepcke, W.; Gerss, J.; Neuringer, M. Nutritional manipulation of primate retinas, V: Effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Investig. Ophthalmol. Vis. Sci. 2011, 52, 3934–3942.
19. Neuringer, M.; Sandstrom, M.M.; Johnson, E.J.; Snodderly, D.M. Nutritional manipulation of primate retinas, I: Effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Investig. Ophthalmol. Vis. Sci. 2004, 45, 3234–3243.
20. Ma, L.; Dou, H.-L.; Wu, Y.-Q.; Huang, Y.-M.; Huang, Y.-B.; Xu, X.-R.; Zou, Z.-Y.; Lin, X.-M. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: A systematic review and meta-analysis. Br. J. Nutr. 2012, 107, 350–359.
21. Kijlstra, A.; Tian, Y.; Kelly, E.R.; Berendschot, T.T.J.M. Lutein: More than just a filter for blue light. Prog. Retin. Eye Res. 2012, 31, 303–315.
22. Age-Related Eye Disease Study 2 (AREDS2) Research Group; Chew, E.Y.; Clemons, T.E.; Sangiovanni, J.P.; Danis, R.P.; Ferris, F.L.; Elman, M.J.; Antoszyk, A.N.; Ruby, A.J.; Orth, D.; et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014, 132, 142–149.
23. Woo, S.J.; Park, K.H.; Ahn, J.; Choe, J.Y.; Jeong, H.; Han, J.W.; Kim, T.H.; Kim, K.W. Cognitive impairment in age-related macular degeneration and geographic atrophy. Ophthalmology 2012, 119, 2094–2101.
24. Vishwanathan, R.; Schalch, W.; Johnson, E.J. Macular pigment carotenoids in the retina and occipital cortex are related in humans. Nutr. Neurosci. 2015, doi:10.1179/1476830514Y. 0000000141
25. Renzi, L.M.; Hammond, B.R. The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision. Ophthalmic Physiol. Opt. 2010, 30, 351–357.
26. Bovier, E.R.; Renzi, L.M.; Hammond, B.R. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency. PLoS ONE 2014, 9, e108178, doi:10.1371/journal.pone.0108178.
27. Johnson, E.J.; McDonald, K.; Caldarella, S.M.; Chung, H.-Y.; Troen, A.M.; Snodderly, D.M. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr. Neurosci. 2008, 11, 75–83.
28. Widomska, J.; Subczynski, W.K. Why has nature chosen lutein and zeaxanthin to protect the retina? J. Clin. Exp. Ophthamol. 2014, 5, 326, doi:10.4172/2155-9570.1000326.
29. Miller, E.; Morel, A.; Saso, L.; Saluk, J. Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases. Oxid. Med. Cell. Longev. 2014, 2014, doi:10.1155/2014/572491.
30. Gruszecki, W.I. Carotenoid orientation: Role in membrane stabilization. In Carotenoids in Health and Disease; Krinsky, N.I., Mayne, S.T., Sies, H., Eds.; Marcel Dekker, Inc.: New York, NY, USA, 2004; pp. 151–164.
31. Stahl, W.; Sies, H. Effects of carotenoids and retinoids on gap junctional communication. BioFactors 2001, 15, 95–98.
32. Sujak, A.; Gabrielska, J.; Grudziński, W.; Borc, R.; Mazurek, P.; Gruszecki, W.I. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects. Arch. Biochem. Biophys. 1999, 371, 301–307.
33. Crabtree, D.V.; Ojima, I.; Geng, X.; Adler, A.J. Tubulins in the primate retina: Evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg. Med. Chem. 2001, 9, 1967–1976.
34. Hulbert, A.J. The links between membrane composition, metabolic rate and lifespan. Comp. Biochem. Physiol. A 2008, 150, 196–203.
35. Söderberg, M.; Edlund, C.; Kristensson, K.; Dallner, G. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 1990, 54, 415–423.
36. Carrié, I.; Portoukalian, J.; Vicaretti, R.; Rochford, J.; Potvin, S.; Ferland, G. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J. Nutr. 2004, 134, 167–172.
37. Seger, C.A.; Cincotta, C.M. Dynamics of frontal, striatal, and hippocampal systems during rule learning. Cereb. Cortex 2006, 16, 1546–1555.
38. Glisky, E.L. Changes in cognitive function in human aging. In Brain Aging: Models, Methods, and Mechanisms; Riddle, D.R., Ed.; CRC Press: Boca Raton, FL, USA, 2007.
39. Sun, Y.; Sun, G.Y. Phospholipids and acyl groups of synaptosomal and myelin membranes isolated from the cerebral cortex of squirrel monkey (Saimiri sciureus). Biochim. Biophys. Acta 1972, 280, 306–315.
40. Tekpli, X.; Holme, J.A.; Sergent, O.; Lagadic-Gossmann, D. Role for membrane remodeling in cell death: Implication for health and disease. Toxicology 2013, 304, 141–157.
41. Farooqui, T.; Farooqui, A.A. Aging: An important factor for the pathogenesis of neurodegenerative diseases. Mech. Ageing Dev. 2009, 130, 203–215.
42. Lu, T.; Pan, Y.; Kao, S.-Y.; Li, C.; Kohane, I.; Chan, J.; Yankner, B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429, 883–891.
43. Fields, R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 2008, 31, 361–370.
44. Lichtenstein, A.H.; Matthan, N.R.; Jalbert, S.M.; Resteghini, N.A.; Schaefer, E.J.; Ausman, L.M. Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 2006, 84, 497–504.
45. Arneson, K.O.; Roberts, L.J. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Methods Enzymol. 2007, 433, 127–143.
46. Walter, M.F.; Blumberg, J.B.; Dolnikowski, G.G.; Handelman, G.J. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal. Biochem. 2000, 280, 73–79.
47. Nie, B.; Gan, W.; Shi, F.; Hu, G.-X.; Chen, L.-G.; Hayakawa, H.; Sekiguchi, M.; Cai, J.-P. Age-dependent accumulation of 8-oxoguanine in the DNA and RNA in various rat tissues. Oxid. Med. Cell. Longev. 2013, 2013, doi:10.1155/2013/303181.
48. Landrum, J.T.; Bone, R.A. Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys. 2001, 385, 28–40.
49. Bernstein, P.S.; Zhao, D.-Y.; Sharifzadeh, M.; Ermakov, I.V.; Gellermann, W. Resonance Raman measurement of macular carotenoids in the living human eye. Arch. Biochem. Biophys. 2004, 430, 163–169.
50. Trieschmann, M.; Heimes, B.; Hense, H.W.; Pauleikhoff, D. Macular pigment optical density measurement in autofluorescence imaging: Comparison of one-and two-wavelength methods. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244, 1565–1574.
51. Wooten, B.R.; Hammond, B.R.; Land, R.I.; Snodderly, D.M. A practical method for measuring macular pigment optical density. Investig. Ophthalmol. Vis. Sci. 1999, 40, 2481–2489.
52. Bone, R.A.; Landrum, J.T.; Friedes, L.M.; Gomez, C.A.; Kilburn, M.D.; Menendez, E.; Vidal, I.; Wang, W. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp. Eye Res. 1997, 64, 211–218.
53. Rapp, L.M.; Maple, S.S.; Choi, J.H. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Investig. Ophthalmol. Vis. Sci. 2000, 41, 1200–1209.
54. Bernstein, P.S.; Delori, F.C.; Richer, S.; van Kuijk, F.J. M.; Wenzel, A.J. The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vis. Res. 2010, 50, 716–728.
55. Sharifzadeh, M.; Zhao, D.-Y.; Bernstein, P.S.; Gellermann, W. Resonance Raman imaging of macular pigment distributions in the human retina. J. Opt. Soc. Am. A 2008, 25, 947–957.
56. Theelen, T.; Berendschot, T.T.J.M.; Klevering, B.J.; Fuijkschot, J.; Hoyng, C.B.; Willemsen, M.A.A.P. Multimodal imaging of the macula in hereditary and acquired lack of macular pigment. Acta Ophthalmol. 2014, 92, 138–142.
57. Charbel Issa, P.; van der Veen, R.L.P.; Stijfs, A.; Holz, F.G.; Scholl, H.P.N.; Berendschot, T.T.J.M. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp. Eye Res. 2009, 89, 25–31.
58. Brignole-Baudouin, F.; Desbenoit, N.; Hamm, G.; Liang, H.; Both, J.-P.; Brunelle, A.; Fournier, I.; Guerineau, V.; Legouffe, R.; Stauber, J.; et al. A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits. PLoS ONE 2012, 7, e50180, doi:10.1371/journal.pone.0050180.
59. Roy, M.C.; Nakanishi, H.; Takahashi, K.; Nakanishi, S.; Kajihara, S.; Hayasaka, T.; Setou, M.; Ogawa, K.; Taguchi, R.; Naito, T. Salamander retina phospholipids and their localization by MALDI imaging mass spectrometry at cellular size resolution. J. Lipid Res. 2011, 52, 463–470.
60. Zemski Berry, K.A.; Gordon, W.C.; Murphy, R.C.; Bazan, N.G. Spatial organization of lipids in the human retina and optic nerve by MALDI imaging mass spectrometry. J. Lipid Res. 2014, 55, 504–515.
61. Sun, N.; Ly, A.; Meding, S.; Witting, M.; Hauck, S.M.; Ueffing, M.; Schmitt-Kopplin, P.; Aichler, M.; Walch, A. High-resolution metabolite imaging of light and dark treated retina using MALDI-FTICR mass spectrometry. Proteomics 2014, 14, 913–923.
62. Hayasaka, T.; Goto-Inoue, N.; Sugiura, Y.; Zaima, N.; Nakanishi, H.; Ohishi, K.; Nakanishi, S.; Naito, T.; Taguchi, R.; Setou, M. Matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight (MALDI-QIT-TOF)-based imaging mass spectrometry reveals a layered distribution of phospholipid molecular species in the mouse retina. Rapid Commun. Mass Spectrom. 2008, 22, 3415–3426.
63. Palmer, A.D.; Griffiths, R.; Styles, I.; Claridge, E.; Calcagni, A.; Bunch, J. Sucrose cryo-protection facilitates imaging of whole eye sections by MALDI mass spectrometry. J. Mass Spectrom. 2012, 47, 237–241.
64. Grey, A.C.; Chaurand, P.; Caprioli, R.M.; Schey, K.L. MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue. J. Proteome Res. 2009, 8, 3278–3283.
65. Anderson, D.M.G.; Ablonczy, Z.; Koutalos, Y.; Spraggins, J.; Crouch, R.K.; Caprioli, R.M.; Schey, K.L. High resolution MALDI imaging mass spectrometry of retinal tissue lipids. J. Am. Soc. Mass Spectrom. 2014, 25, 1394–1403.
66. Lanni, E.J.; Rubakhin, S.S.; Sweedler, J.V. Mass spectrometry imaging and profiling of single cells. J. Proteomics 2012, 75, 5036–5051.
67. Zimmerman, T.A.; Rubakhin, S.S.; Sweedler, J.V. MALDI mass spectrometry imaging of neuronal cell cultures. J. Am. Soc. Mass Spectrom. 2011, 22, 828–836.
68. Rubakhin, S.S.; Sweedler, J.V. Mass Spectrometry Imaging; Humana Press: New York, NY, USA, 2010.
69. Snodderly, D.M.; Handelman, G.J.; Adler, A.J. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Investig. Ophthalmol. Vis. Sci. 1991, 32, 268–279.
70. Van Lieshout, M.; West, C.E.; van Breemen, R.B. Isotopic tracer techniques for studying the bioavailability and bioefficacy of dietary carotenoids, particularly beta-carotene, in humans: A review. Am. J. Clin. Nutr. 2003, 77, 12–28.
71. Burri, B.J.; Clifford, A.J. Carotenoid and retinoid metabolism: Insights from isotope studies. Arch. Biochem. Biophys. 2004, 430, 110–119.
72. Khachik, F.; Chang, A.-N. Total synthesis of (3R,3′R,6′R)-lutein and its stereoisomers. J. Org. Chem. 2009, 74, 3875–3885.
73. Borowitzka, M.A. Commercial production of microalgae: Ponds, tanks, tubes and fermenters. J. Biotechnol. 1999, 70, 313–321.
74. Lu, C.-H.; Choi, J.-H.; Engelmann Moran, N.; Jin, Y.-S.; Erdman, J.W. Laboratory-scale production of 13C-labeled lycopene and phytoene by bioengineered Escherichia coli. J. Agric. Food Chem. 2011, 59, 9996–10005.
75. Campbell, J.K.; Rogers, R.B.; Lila, M.A.; Erdman, J.W. Biosynthesis of 14C-phytoene from tomato cell suspension cultures (Lycopersicon esculentum) for utilization in prostate cancer cell culture studies. J. Agric. Food Chem. 2006, 54, 747–755.
76. Moran, N.E.; Rogers, R.B.; Lu, C.-H.; Conlon, L.E.; Lila, M.A.; Clinton, S.K.; Erdman, J.W. Biosynthesis of highly enriched 13C-lycopene for human metabolic studies using repeated batch tomato cell culturing with 13C-glucose. Food Chem. 2013, 139, 631–639.
77. Gowik, U.; Westhoff, P. The path from C3 to C4 photosynthesis. Plant Physiol. 2011, 155, 56–63.
78. Liang, Y.; White, W.S.; Yao, L.; Serfass, R.E. Use of high-precision gas isotope ratio mass spectrometry to determine natural abundance 13C in lutein isolated from C3 and C4 plant sources. J. Chromatogr. A 1998, 800, 51–58.
79. Lu, C.-H.; Engelmann, N.J.; Lila, M.A.; Erdman, J.W. Optimization of lycopene extraction from tomato cell suspension culture by response surface methodology. J. Agric. Food Chem. 2008, 56, 7710–7714.
80. Engelmann, N.J.; Campbell, J.K.; Rogers, R.B.; Rupassara, S.I.; Garlick, P.J.; Lila, M.A.; Erdman, J.W. Screening and selection of high carotenoid producing in vitro tomato cell culture lines for [13C]-carotenoid production. J. Agric. Food Chem. 2010, 58, 9979–9987.